A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
Public ClinicalTrials.gov record NCT02296892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy
Study identification
- NCT ID
- NCT02296892
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Paion UK Ltd.
- Industry
- Enrollment
- 446 participants
Conditions and interventions
Conditions
Interventions
- Remimazolam Drug
- Placebo Drug
- Midazolam Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- Feb 28, 2017
- Completion
- Mar 12, 2017
- Last update posted
- Mar 17, 2020
2015 – 2017
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pab Clinical Research | Brandon | Florida | 33511 | — |
| Sun City Office | Sun City Center | Florida | 33573 | — |
| Laporte County Institute For Clinical Research | Michigan City | Indiana | 46360 | — |
| The Johns Hopkins Center for Interventional and Pulmonary Care | Baltimore | Maryland | 21287 | — |
| Washington University School of Medicine/Barnes-Jewish Hospital | St Louis | Missouri | 63110 | — |
| Unc Division of Pulmonary and Critical Care | Chapel Hill | North Carolina | 27599 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Pinehurst Medical Clinic | Pinehurst | North Carolina | 28374 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| S. Carolina Pharmaceutical Research | Spartanburg | South Carolina | 29303 | — |
| Pulmonary Associates of Richmond | Richmond | Virginia | 23225 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Multicare Institute For Research & Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02296892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2020 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02296892 live on ClinicalTrials.gov.